Red docente para el seguimiento de las Prácticas Externas. Facultad de Filosofía y Letras

La presente memoria es el resultado del trabajo realizado durante el curso académico 2013-2014 por la Red docente para el seguimiento de las Prácticas Externas en la Facultad de Filosofía y Letras en el marco del Proyecto «Redes de Investigación en docencia universitaria». Esta Red ha contado con la colaboración de los diferentes tutores académicos de las diez Titulaciones de nuestra Facultad: Estudios Ingleses, Filología Catalana, Español: Lengua y Literaturas, Estudios Franceses, Estudios Árabes e Islámicos, Geografía y Ordenación del Territorio, Historia, Humanidades, Traducción e Interpretación y Turismo; así como con la inestimable labor de la Gestora de Prácticas en Empresa: Ana Belén Martín-Portugués Giménez de los Galanes. El propósito fundamental de la Red ha sido efectuar un seguimiento de las prácticas curriculares tras su primer año de funcionamiento como asignatura en los distintos Grados. Para ello, no solo se ha reflexionado acerca de los posibles problemas que han ido surgiendo y de las posibles propuestas de mejora, sino también se ha llevado a cabo una revisión de la documentación existente para el seguimiento de las prácticas y para su evaluación, con el fin de que se adecue a lo que se nos exigirá en la acreditación de los Títulos

Implementación de la perspectiva de género en la docencia universitaria de la Facultad de Filosofía y Letras

La Red de investigación en docencia universitaria Implementación de la perspectiva de género en la docencia universitaria de la Facultad de Filosofía y Letras, comprometida con la inclusión de perspectiva de género en los estudios de Grado y Máster que en ella se imparten, y al amparo de la legislación y normativa vigentes en materia de igualdad entre mujeres y hombres, ha realizado durante el segundo cuatrimestre una propuesta de indicadores de género que pueda ser útil a todo el profesorado de la Facultad. Los indicadores están relacionados con tres aspectos: los contenidos, la bibliografía y el uso de un lenguaje inclusivo y no sexista. Estos tres elementos están siempre presentes en los materiales docentes que se ponen a disposición del alumnado. Los resultados obtenidos complementan el Objetivo 2 del Eje 2 (Docencia) del 2.º Plan de Igualdad de oportunidades entre mujeres y hombres de la Universidad de Alicante, 2014-2016: “Integrar la perspectiva de género en la docencia universitaria. Acción 7. Impulsar la inclusión, tanto de forma específica como transversal, del significado y alcance de la igualdad de mujeres y hombres en los contenidos y competencias de los planes de estudio de grado y posgrado de la UA”

Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU : A multicentre retrospective cohort study

It is unclear whether the changes in critical care throughout the pandemic have improved the outcomes in coronavirus disease 2019 (COVID-19) patients admitted to the intensive care units (ICUs). We conducted a retrospective cohort study in adults with COVID-19 pneumonia admitted to 73 ICUs from Spain, Andorra and Ireland between February 2020 and March 2021. The first wave corresponded with the period from February 2020 to June 2020, whereas the second/third waves occurred from July 2020 to March 2021. The primary outcome was ICU mortality between study periods. Mortality predictors and differences in mortality between COVID-19 waves were identified using logistic regression. As of March 2021, the participating ICUs had included 3795 COVID-19 pneumonia patients, 2479 (65·3%) and 1316 (34·7%) belonging to the first and second/third waves, respectively. Illness severity scores predicting mortality were lower in the second/third waves compared with the first wave according with the Acute Physiology and Chronic Health Evaluation system (median APACHE II score 12 [IQR 9-16] vs 14 [IQR 10-19]) and the organ failure assessment score (median SOFA 4 [3-6] vs 5 [3-7], p <0·001). The need of invasive mechanical ventilation was high (76·1%) during the whole study period. However, a significant increase in the use of high flow nasal cannula (48·7% vs 18·2%, p <0·001) was found in the second/third waves compared with the first surge. Significant changes on treatments prescribed were also observed, highlighting the remarkable increase on the use of corticosteroids to up to 95.9% in the second/third waves. A significant reduction on the use of tocilizumab was found during the study (first wave 28·9% vs second/third waves 6·2%, p <0·001), and a negligible administration of lopinavir/ritonavir, hydroxychloroquine, and interferon during the second/third waves compared with the first wave. Overall ICU mortality was 30·7% (n = 1166), without significant differences between study periods (first wave 31·7% vs second/third waves 28·8%, p = 0·06). No significant differences were found in ICU mortality between waves according to age subsets except for the subgroup of 61-75 years of age, in whom a reduced unadjusted ICU mortality was observed in the second/third waves (first 38·7% vs second/third 34·0%, p = 0·048). Non-survivors were older, with higher severity of the disease, had more comorbidities, and developed more complications. After adjusting for confounding factors through a multivariable analysis, no significant association was found between the COVID-19 waves and mortality (OR 0·81, 95% CI 0·64-1·03; p = 0·09). Ventilator-associated pneumonia rate increased significantly during the second/third waves and it was independently associated with ICU mortality (OR 1·48, 95% CI 1·19-1·85, p <0·001). Nevertheless, a significant reduction both in the ICU and hospital length of stay in survivors was observed during the second/third waves. Despite substantial changes on supportive care and management, we did not find significant improvement on case-fatality rates among critical COVID-19 pneumonia patients. Ricardo Barri Casanovas Foundation (RBCF2020) and SEMICYU

Los contenidos de consumo en las diversas asignaturas de BUP y COU

No presenta memoriaTrata la Educación del consumidor enumerando los aspectos a tratar en BUP y COU y los contenidos en las diversas asignaturas. Pretende desarrollar las asignaturas convencionales desde la perspectiva del consumo, contribuir con ello a la formación del consumidor y dar una idea multidisciplinar del consumo. Las actividades se desarrollan a partir de trabajos de campo, laboratorio, entrevistas, mesas redondas, audiciones y visitas utilizando bibliografías, textos cartografía y prensa. Evalúa el grado de consecución de habilidades psicomotrices, de investigación y experimentación; las actitudes; los contenidos; la modificación de hábitos y el grado de interés suscitado, a partir del trabajo del alumnado y de pruebas objetivas.Madrid (Comunidad Autónoma). Consejería de Educación y CulturaMadridMadrid (Comunidad Autónoma). Subdirección General de Formación del Profesorado. CRIF Las Acacias; General Ricardos 179 - 28025 Madrid; Tel. + 34915250893ES

Smart rural tourism. Training applied within the framework of the European SmartRural project

Desde noviembre de 2019, la Universidad de Alicante, a través del grupo de investigación de Geografía Humana, participa como partner en el proyecto europeo Smartrural. Su objetivo, identificar las brechas existentes y las mejores prácticas de los países de la UE para desarrollar un programa de capacitación en turismo rural inteligente dirigido a estudiantes, autoridades y comunidades locales (stakeholders). En total son siete universidades implicadas. El objeto de la comunicación es ilustrar el proceso seguido hasta la fecha, para determinar el contenido del programa formativo, asignaturas y metodología para su desarrollo, que luego se tendrá que testar para sacar aprendizajes que mejoren el producto final (MOOC). La Universidad de Alicante, aporta el valor de la geografía en el desarrollo de estos programas formativos, vinculados al turismo, reforzando la importancia del enfoque rural integrado y territorial, teniendo como pilar fundamental a la población local. Sin olvidar, los aspectos tecnológicos, que deben hacer a estos “espacios rurales inteligentes”, accesibles, conectivos y participativos, procurando también al turista la posibilidad de mejorar su experiencia. Todo ello combinando teoría y práctica, sapiencia y experiencias.Since November 2019, the University of Alicante, through the Human Geography research group, participates as a partner in the European Smartrural project. Its objective is to identify the existing gaps and best practices in the EU countries to develop a training program in smart rural tourism aimed at students, authorities and local communities (stakeholders). In total there are seven universities involved. The purpose of the communication is to illustrate the process followed to date, determine the content of the training program, the topics and the methodology for its development, which must then be tested to obtain learning that improves the final product. The University of Alicante contributes the value of geography in the development of these training programs, linked to tourism, reinforcing the importance of an integrated rural and territorial approach, with the local population as a fundamental pillar. Without forgetting the technological aspects that must make these "smart rural spaces" accessible, connected and participatory, and that also offer tourists the possibility of improving their experience. All of this combines theory and practice, knowledge and experience

Good Practices Within the European Project Smart Rural

Since November 2019, the University of Alicante, through the Human Geography research group, has participated as a partner in the European Smart rural project. Its objective is to identify the existing gaps and best practices in the EU countries to develop a training program in smart rural tourism aimed at students, authorities, and local communities (stakeholders). In total there are seven universities involved. The purpose of the communication is to illustrate the process followed to date, determine the content of the training program, the topics and the methodology for its development, which must then be tested to obtain learning that improves the final product. The University of Alicante contributes the value of geography in the development of these training programs linked to tourism, reinforcing the importance of an integrated rural and territorial approach, with the local population as a fundamental pillar. It also provides an analysis of the good practices of each of the partners and a methodological guide.2019–1- TRO1-KA203–073781. “Towards an intelligent development of rural tourism in Europe” (K203-Erasmus+)

Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients.

Procalcitonin (PCT) and C-Reactive Protein (CRP) are useful biomarkers to differentiate bacterial from viral or fungal infections, although the association between them and co-infection or mortality in COVID-19 remains unclear. The study represents a retrospective cohort study of patients admitted for COVID-19 pneumonia to 84 ICUs from ten countries between (March 2020-January 2021). Primary outcome was to determine whether PCT or CRP at admission could predict community-acquired bacterial respiratory co-infection (BC) and its added clinical value by determining the best discriminating cut-off values. Secondary outcome was to investigate its association with mortality. To evaluate the main outcome, a binary logistic regression was performed. The area under the curve evaluated diagnostic performance for BC prediction. 4635 patients were included, 7.6% fulfilled BC diagnosis. PCT (0.25[IQR 0.1-0.7] versus 0.20[IQR 0.1-0.5]ng/mL, p These biomarkers at ICU admission led to a poor ability to predict BC among patients with COVID-19 pneumonia. Baseline values of PC

Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19 : a meta-analysis

IMPORTANCE Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized for COVID-19 have variously reported benefit, no effect, and harm. OBJECTIVE To estimate the association between administration of IL-6 antagonists compared with usual care or placebo and 28-day all-cause mortality and other outcomes. DATA SOURCES Trials were identified through systematic searches of electronic databases between October 2020 and January 2021. Searches were not restricted by trial status or language. Additional trials were identified through contact with experts. STUDY SELECTION Eligible trials randomly assigned patients hospitalized for COVID-19 to a group in whom IL-6 antagonists were administered and to a group in whom neither IL-6 antagonists nor any other immunomodulators except corticosteroids were administered. Among 72 potentially eligible trials, 27 (37.5%) met study selection criteria. DATA EXTRACTION AND SYNTHESIS In this prospectivemeta-analysis, risk of biaswas assessed using the Cochrane Risk of Bias Assessment Tool. Inconsistency among trial results was assessed using the I-2 statistic. The primary analysis was an inverse variance-weighted fixed-effects meta-analysis of odds ratios (ORs) for 28-day all-cause mortality. MAIN OUTCOMES AND MEASURES The primary outcome measurewas all-cause mortality at 28 days after randomization. There were 9 secondary outcomes including progression to invasive mechanical ventilation or death and risk of secondary infection by 28 days. RESULTS A total of 10 930 patients (median age, 61 years [range of medians, 52-68 years]; 3560 [33%] were women) participating in 27 trials were included. By 28 days, there were 1407 deaths among 6449 patients randomized to IL-6 antagonists and 1158 deaths among 4481 patients randomized to usual care or placebo (summary OR, 0.86 [95% CI, 0.79-0.95]; P =.003 based on a fixed-effects meta-analysis). This corresponds to an absolute mortality risk of 22% for IL-6 antagonists compared with an assumed mortality risk of 25% for usual care or placebo. The corresponding summary ORs were 0.83 (95% CI, 0.74-0.92; P <.001) for tocilizumab and 1.08 (95% CI, 0.86-1.36; P =.52) for sarilumab. The summary ORs for the association with mortality compared with usual care or placebo in those receiving corticosteroids were 0.77 (95% CI, 0.68-0.87) for tocilizumab and 0.92 (95% CI, 0.61-1.38) for sarilumab. The ORs for the association with progression to invasive mechanical ventilation or death, compared with usual care or placebo, were 0.77 (95% CI, 0.70-0.85) for all IL-6 antagonists, 0.74 (95% CI, 0.66-0.82) for tocilizumab, and 1.00 (95% CI, 0.74-1.34) for sarilumab. Secondary infections by 28 days occurred in 21.9% of patients treated with IL-6 antagonists vs 17.6% of patients treated with usual care or placebo (OR accounting for trial sample sizes, 0.99; 95% CI, 0.85-1.16). CONCLUSIONS AND RELEVANCE In this prospectivemeta-analysis of clinical trials of patients hospitalized for COVID-19, administration of IL-6 antagonists, compared with usual care or placebo, was associated with lower 28-day all-cause mortality